Asensus Surgical, a prominent player in digital operating room solutions, has officially been acquired by KARL STORZ Group. The transaction, which saw KARL STORZ purchase Asensus Surgical for $0.35 per share in cash, has resulted in Asensus becoming a subsidiary of KARL STORZ, and its shares are no longer traded on the NYSE American Exchange. Both companies anticipate significant strategic benefits from the merger. Asensus’ expertise in robotic surgery will complement KARL STORZ’s expansive portfolio in surgical solutions, particularly boosting the development of the next-generation LUNA System. This system, although still under development, is expected to offer enhanced precision, dexterity and manipulation range, aligning perfectly with KARL STORZ’s advanced visualization capabilities. The union is expected to lead to superior patient outcomes worldwide. Legal and financial advisors for both sides were, respectively, Jefferies LLC/Ballard Spahr LLP for Asensus and UBS Investment Bank/Ropes & Gray LLP for KARL STORZ.
Medical Technology, Endoscopy, Robotic Surgery,United States, Germany
https://www.globenewswire.com/news-release/2024/08/22/2934222/0/en/Asensus-Surgical-Announces-Closing-of-Acquisition-by-KARL-STORZ.html